As part of its answer to suspended owner/driver Jeremy Mayfield's legal action, NASCAR on Friday countersued Mayfield in federal court for violating NASCAR's substance abuse policy, breach of contract and fraud.
"NASCAR today responded to Jeremy Mayfield's lawsuit by denying each of his claims and countersuing Mayfield for violating NASCAR's substance abuse policy, breach of contract and defrauding NASCAR and its competitors of earnings," Ramsey Poston, managing director of corporate communications for the sanctioning body, confirmed.
"NASCAR's counterclaims state that Mayfield knowingly participated in NASCAR-sanctioned competition using a combination of drugs in violation of the substance abuse policy and, in doing so, violated his contract with NASCAR and the standards of care that he owes fellow drivers and spectators."
NASCAR suspended Mayfield on 9 May after a failed drug test. Mayfield claimed that the positive drug test resulted from a combination of prescription Adderall-XR and over-the-counter Claritin-D, which he took for allergies.
Mayfield sought a temporary restraining order in state court in Charlotte, the granting of which would have allowed him to drive, but NASCAR moved the case to federal court, and a hearing date has not yet been set.
NASCAR claims in its filing that Mayfield's test revealed an illegal drug, but the sanctioning body also took issue with Mayfield's use of the Adderall-XR.
"In addition to the use of illegal drugs, Mayfield has now admitted that he used another drug without informing NASCAR," Poston said, "When he consumed that drug in conjunction with another medication, he exceeded safe levels and violated NASCAR's substance abuse policy."
by Reid Spencer
Sporting News NASCAR Wire Service